A drug’s chemical category does not settle every clinical similarity to benzodiazepines.
A case report described escalating zolpidem use followed by seizures after interruption. The patient recovered with clinical care. The report challenged assumptions that a non-benzodiazepine hypnotic cannot produce dependence or withdrawal phenomena.
One case cannot establish incidence or a minimum safe or hazardous dose. Zolpidem is not a benzodiazepine, and the findings should not be relabeled as direct evidence about a particular benzodiazepine.
Separate chemical classification, receptor activity and the patient’s dosing history. For withdrawal reconstruction, document the last confirmed dose and alternative seizure causes. A published case can identify a possibility without establishing that the same mechanism explains another person’s event.
Source: PMC4329938, supplied full-text paper. Findings are paraphrased; case-review implications are an interpretation.
Related: Forensic Toxicology: expert analysis and case review.